Schneeweiss MC, Glynn RJ, Wyss R, Anand P, et al. A scalable approach to assess the safety of recently marketed systemic treatments for atopic dermatitis in clinical practice. J Invest Dermatol 2024 Oct 1:S0022-202X(24)02169.
PMID: 39362623